Page results
-
UCLH and UCL neurologists have published the first clinical observations of patients who experienced an ischaemic stroke, the most common form of stroke, following an Oxford AstraZeneca vaccine.
-
A BBC One documentary featuring clinicians at UCLH which airs this Thursday highlights the harm to the body and brain caused by ultra-processed food.
-
More people with dementia in the UK will be able to take part in research and help accelerate the development of new treatments, as the Government announces £49.9 million of new funding to build a network of dementia trials sites across the country.
-
Five cases of Alzheimer’s disease are believed to have arisen as a result of medical treatments decades earlier, reports a team of UCL and UCLH researchers.
-
Prime Minister Boris Johnson visited the vaccination centre at the Islington Business Design Centre yesterday.
-
Researchers at UCLH and Imperial College Healthcare NHS Trust are to trial a new weight loss treatment which involves reducing blood supply to part of the stomach.
-
Our neonatal service is a recognised centre of excellence caring for acutely ill and preterm babies from our local area and beyond.
-
UCLH is to host to a new collaboration researching patient safety, after being awarded £3million in funding.
-
UCLH is to lead an initiative to improve care for myeloma patients alongside Oxford University Hospitals NHS Foundation Trust (OUH) and University Hospital Southampton NHS Foundation Trust (UHS).
-
At University College London Hospitals NHS Foundation Trust (UCLH) we value our reputation for top quality care and financial probity and conduct our business in an ethical manner.
File results
-
FOI/2023/0282 - British Medical Association (BMA) strikes - cancelled, delayed or missed appointments
-
FOI/2023/0284 - IT services management platform/ user licences
-
FOI/2023/0286 - Maternity services budget for 2018/19-2022/23
-
FOI/2023/0288 - Cancer treatment capacity
-
FOI/2023/0290 - Specialist palliative care units within the Trust
-
FOI/2023/0294 - Patient entertainment
-
FOI/2023/0319 - Multiple Sclerosis (MS) treatment/ medication for any diseases
-
FOI/2023/0326 - Risk management system reporting rates for adverse events
-
FOI/2023/0323 - Medications/ treatment for dermatology and respiratory medicine
-
FOI/2023/0327 - NHS long-term plan/ prevention strategy